As the Trade Association which represents the pharmaceutical companies who develop new innovative medicines, the ABPI strongly welcomes the announcement today of a New Treatment Fund in Wales by Vaughan Gething AM, Cabinet Secretary for Health Well-being and Sport.
"The intentions of the Welsh Government to financially support the introduction and use of medicines with a proven evidence base is both re-assuring and progressive. The confirmed investment of £80 million, over the life of this government, to support the early introduction of the newest and most innovative medicines recommended by NICE or AWMSG has the potential to make significant 'life changing' improvements for patients in Wales. We understand the challenges faced by NHS Wales to plan and prioritise expenditure on newer medicines and we are hopeful that NHS Wales will maximise the opportunity this early funding stream will offer.
We look forward to working with the Welsh Government and others to work through the details of the New Treatment Fund and the review of the Individual Patient Funding Request process."
Rick Greville, Director - ABPI Wales